MedPath

Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

Not Applicable
Completed
Conditions
Preterm Labor
Interventions
Registration Number
NCT02262481
Lead Sponsor
Chulalongkorn University
Brief Summary

The purpose of this study is to evaluate the effect of oral progesterone supplementation in preterm labor on the prevention of recurrent uterine contraction and prolonging pregnancy period, and its side effect.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
48
Inclusion Criteria
  • Singleton pregnancy
  • Preterm labor
  • GA24-34wk
  • Intact membranes
Read More
Exclusion Criteria
  • Maternal/fetal condition requiring immediate delivery ex. Chorioamnionitis, fetal distress
  • Placenta previa
  • medical and obstetric complications
  • allergy to dydrogesterone
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placeboplacebotocolytic + corticosteroids + Placebo prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks
Dydrogesteronedydrogesteronetocolytic + corticosteroids + Dydrogesterone 10 mg/tablet prepare in capsule, 1 cap oral every 12 hours, starting form enrollment until gestational age 37 weeks
Primary Outcome Measures
NameTimeMethod
The recurrence of uterine contraction within 48 hours after stop tocolytic48 hours
Secondary Outcome Measures
NameTimeMethod
side effects9 weeks
Number of newborn with intraventricular hemorrhage9 weeks
Number of newborn with necrotizing enterocolitis9 weeks
Number of newborn with sepsis9 weeks
Time from preterm labor pain to delivery9 weeks
Number of newborn with respiratory distress syndrome9 weeks
Gestational age at delivery9 weeks

Trial Locations

Locations (1)

Faculty of Medicine, Chulalongkorn University

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath